ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02311920
Brief Title: Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

First Submitted : December 8, 2014
First Submitted that Met QC Criteria : December 8, 2014
First Posted : December 9, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : June 20, 2018
Last Update Posted : June 21, 2018 (Estimate)